Annual General Meeting 2022

Annual General Meeting 2022

Annual General Meeting 2022

The 2022 Annual General Meeting of BioNTech SE will be held on June 1, 2022 at 14:00 (CEST), online, without the presence of shareholders or their proxies.

Video and audio transmission of the entire Annual General Meeting

All shareholders and ADS holders of the Company and interested members of the public can follow the entire Annual General Meeting on Wednesday, 1 June 2022, from 2:00 p.m. (CEST) via this page.

Frequently Asked Questions (FAQ)

Investor Portal of BioNTech SE

Shareholders and their proxies can register for the AGM, appoint proxies and cast their votes on the AGM resolutions via the INVESTOR PORTAL below:

Please note the registration deadline of Wednesday, May 25, 2022, 24:00 (CEST).

Further details about how shareholders can exercise their voting rights and ask questions can be found in the section “III. Further Details” in the AGM Invitation.

Holders of American Depositary Shares (ADSs) issued by The Bank of New York Mellon (BNYM) should contact BNYM or their broker bank to obtain the voting information.

INFORMATION AND DOCUMENTS FOR THE VIRTUAL ANNUAL GENERAL MEETING

Invitation to the Annual General Meeting 2022

Invitation to the Annual General Meeting 2022

Table pursuant to Sec. 125 Stock Corporation Act in conjunction with EU Regulation 2018/1212 - ISIN 1

Table pursuant to Sec. 125 Stock Corporation Act in conjunction with EU Regulation 2018/1212 – ISIN 2

 

Documents on Agenda Items 1 and 10

BioNTech Annual Report 2021

BioNTech SE Annual Financial Statements 2021 (German version only) (Auditor Report – German version only)

BioNTech SE Consolidated Financial Statements 2021

BioNTech Combined Management Report 2021

Report of the Supervisory Board on the 2021 Financial Year

 

Explanation to Agenda Item 1

Explanation to Agenda Item 1 Sec. 124a Sentence 1 No. 2 Stock Corporation Act

 

Documents on Agenda Item 6

Remuneration Report 2021 (Auditor report) 

 

Documents on Agenda Item 8

CV Prof. Dr. Anja Morawietz

CV Prof. Dr. Rudolf Staudigl

CV Mr Helmut Jeggle

 

Including other information relevant to the proposed elections to the Supervisory Board

 

Documents on Agenda Item 9

Remuneration System for the members of the Supervisory Board of BioNTech SE

 

Documents on Agenda items 7 and 9

BioNTech SE Articles of Association

 

Documents on agenda item 10

BioNTech Innovation GmbH

Domination and Profit and Loss Transfer Agreement between BioNTech SE and BioNTech Innovation GmbH

Joint Report pursuant to Sec. 293 Stock Corporation Act of BioNTech SE and BioNTech Innovation GmbH for the Domination and Profit and Loss Transfer Agreement

BioNTech Innovation GmbH Closing Balance Sheet; Profit and Loss 2021 (German version only)

 

BioNTech Innovation and Services Marburg GmbH

Domination and Profit and Loss Transfer Agreement between BioNTech SE and BioNTech Innovation and Services Marburg GmbH

Joint Report pursuant to Sec. 293 Stock Corporation Act of BioNTech SE and BioNTech Innovation and Services Marburg GmbH for the Domination and Profit and Loss Transfer Agreement

BioNTech Innovation and Services Marburg GmbH Closing Balance Sheet; Profit and Loss 2021(German version only)

 

BioNTech SE

Annual Financial Statements of BioNTech SE 2019

Management Report of BioNTech SE 2019

Annual Financial Statements of BioNTech SE 2020

Combined Management Report of BioNTech SE 2020

Annual Financial Statements of BioNTech SE 2021 (German version only)

Combined Management Report of BioNTech SE 2021

 

Further Documents and Forms

Explanation of Shareholder Rights

Registration, Voting and Proxy Form

Notes on Data Protection

 

Total Number of Shares and Voting Rights

Total Number of Shares and Voting Rights

 

Countermotions and Election Proposals

There are currently no countermotions and election proposals from shareholders.

 

Speech and Presentation

AGM Speech of CEO and CFO

Presentation

 

Voting Results

Results of the outcome of votes of the 2022 Annual General Meeting